Delivery Order SPE2DB22D2006-SPE2DB25FW2NN
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on July 11, 2025, with a ceiling value of $3,082.67 and an ultimate completion date of August 1, 2025. This competitive award, issued under firm fixed pricing, represents a single delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $12,994.64 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of December 23, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Defense Health Agency and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors. This competitively awarded, non-set-aside contract was finalized on July 31, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract utilizes firm fixed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,491.96 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on December 9, 2025. This firm fixed-price delivery order, which carries a completion date of December 31, 2025, was competitively awarded with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injectors. The contract, which was competitively awarded without set-aside restrictions, carries a firm fixed price structure with an ultimate completion date of October 14, 2025. Performance will be executed from AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Benlysta 200 mg/ml auto-injector pharmaceutical product. This firm fixed-price delivery order, valued at $6,165.36, is scheduled for completion by November 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under an existing contract vehicle, demonstrating the contractor's...
- The Defense Logistics Agency awarded a $18,496.02 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical product on August 14, 2025, with completion targeted for September 5, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, to be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 12, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at...
- The Defense Logistics Agency awarded a $3,248.66 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Benlysta 200 mg/mL auto-injector. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside contract with a completion date of September 25, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2NNDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract for Benlysta 200 mg/ml auto-injector by the Defense Logistics Agency (DLA) on July 15, 2025. The competitively awarded, non-set-aside contract carries a ceiling value of $6,165.34 and is structured as a firm fixed price delivery order with an ultimate completion date of August 5, 2025. The pharmaceutical product will be supplied to support federal medical procurement needs, with place of performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare systems worldwide. AmerisourceBergen Drug Corp's substantial federal contract portfolio with the DLA Medical Supply Chain demonstrates its capability as a critical vendor for federal medical procurement, delivering specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 7/15/25 |